SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Pavot A)
 

Sökning: WFRF:(Pavot A) > (2020-2021) > Preexisting autoant...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004224naa a2201021 4500
001oai:prod.swepub.kib.ki.se:147389237
003SwePub
008240701s2021 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1473892372 URI
024a https://doi.org/10.1084/jem.202105542 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Bastard, P4 aut
2451 0a Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
264 c 2021-04-23
264 1b Rockefeller University Press,c 2021
520 a Patients with biallelic loss-of-function variants of AIRE suffer from autoimmune polyendocrine syndrome type-1 (APS-1) and produce a broad range of autoantibodies (auto-Abs), including circulating auto-Abs neutralizing most type I interferons (IFNs). These auto-Abs were recently reported to account for at least 10% of cases of life-threatening COVID-19 pneumonia in the general population. We report 22 APS-1 patients from 21 kindreds in seven countries, aged between 8 and 48 yr and infected with SARS-CoV-2 since February 2020. The 21 patients tested had auto-Abs neutralizing IFN-α subtypes and/or IFN-ω; one had anti–IFN-β and another anti–IFN-ε, but none had anti–IFN-κ. Strikingly, 19 patients (86%) were hospitalized for COVID-19 pneumonia, including 15 (68%) admitted to an intensive care unit, 11 (50%) who required mechanical ventilation, and four (18%) who died. Ambulatory disease in three patients (14%) was possibly accounted for by prior or early specific interventions. Preexisting auto-Abs neutralizing type I IFNs in APS-1 patients confer a very high risk of life-threatening COVID-19 pneumonia at any age.
700a Orlova, E4 aut
700a Sozaeva, L4 aut
700a Levy, R4 aut
700a James, A4 aut
700a Schmitt, MM4 aut
700a Ochoa, S4 aut
700a Kareva, M4 aut
700a Rodina, Y4 aut
700a Gervais, A4 aut
700a Le Voyer, T4 aut
700a Rosain, J4 aut
700a Philippot, Q4 aut
700a Neehus, AL4 aut
700a Shaw, E4 aut
700a Migaud, M4 aut
700a Bizien, L4 aut
700a Ekwall, O4 aut
700a Berg, S4 aut
700a Beccuti, G4 aut
700a Ghizzoni, L4 aut
700a Thiriez, G4 aut
700a Pavot, A4 aut
700a Goujard, C4 aut
700a Fremond, ML4 aut
700a Carter, E4 aut
700a Rothenbuhler, A4 aut
700a Linglart, A4 aut
700a Mignot, B4 aut
700a Comte, A4 aut
700a Cheikh, N4 aut
700a Hermine, O4 aut
700a Breivik, L4 aut
700a Husebye, ES4 aut
700a Humbert, S4 aut
700a Rohrlich, P4 aut
700a Coaquette, A4 aut
700a Vuoto, F4 aut
700a Faure, K4 aut
700a Mahlaoui, N4 aut
700a Kotnik, P4 aut
700a Battelino, T4 aut
700a Podkrajsek, KT4 aut
700a Kisand, K4 aut
700a Ferre, EMN4 aut
700a DiMaggio, T4 aut
700a Rosen, LB4 aut
700a Burbelo, PD4 aut
700a McIntyre, M4 aut
700a Kann, NY4 aut
700a Shcherbina, A4 aut
700a Pavlova, M4 aut
700a Kolodkina, A4 aut
700a Holland, SM4 aut
700a Zhang, SY4 aut
700a Crow, YJ4 aut
700a Notarangelo, LD4 aut
700a Su, HC4 aut
700a Abel, L4 aut
700a Anderson, MS4 aut
700a Jouanguy, E4 aut
700a Neven, B4 aut
700a Puel, A4 aut
700a Casanova, JL4 aut
700a Lionakis, MS4 aut
773t The Journal of experimental medicined : Rockefeller University Pressg 218:7q 218:7x 1540-9538x 0022-1007
856u https://rupress.org/jem/article-pdf/218/7/e20210554/1413883/jem_20210554.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:147389237
8564 8u https://doi.org/10.1084/jem.20210554

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy